← Eichor
Condition: Recurrent Malignant Glioma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Recurrent Malignant Glioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · 1 location(s) · Beijing Biotech · NCT07480941[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
EARLY_Phase 1 · 2 location(s) · Beijing Tiantan Hospital · NCT07655869Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Ref
Phase 2 · 1 location(s) · Northwell Health · NCT02800486MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Phase 1/Phase 2 · 3 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT06712875Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
Phase 1 · 1 location(s) · Henry Ford Health System · NCT05686798Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
Phase 1 · 1 location(s) · Plus Therapeutics · NCT05460507ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
Phase 1 · 1 location(s) · Mayo Clinic · NCT05917145CARv3-TEAM-E T Cells in Glioblastoma
Phase 1 · 1 location(s) · Marcela V. Maus, M.D.,Ph.D. · NCT05660369Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
Phase 1 · 4 location(s) · Tcelltech Inc. · NCT06482905Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progress
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06815029Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
Phase 1 · 1 location(s) · Darell Bigner · NCT04547777PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial
NA · 2 location(s) · Baptist Health South Florida · NCT06397560The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06283927ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Phase 1 · 7 location(s) · Sabine Mueller, MD, PhD · NCT04732065Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06964737PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Phase 2 · 13 location(s) · Nationwide Children's Hospital · NCT05096481A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) M
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05588141Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma
Phase 1 · 1 location(s) · NanoPharmaceuticals LLC · NCT05226494Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
Phase 1 · 1 location(s) · Beijing Neurosurgical Institute · NCT06585527Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
Phase 1 · 17 location(s) · University of California, San Francisco · NCT04485559Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma
Phase 3 · 1 location(s) · The Third Affiliated hospital of Zhejiang Chinese Medical Un · NCT06330337ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Phase 2 · 20 location(s) · Nationwide Children's Hospital · NCT06838676A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Phase 1 · 1 location(s) · University of Nebraska · NCT05698524DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma o
Phase 2 · 1 location(s) · Ashish Shah · NCT06264388Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection
Phase 1/Phase 2 · 1 location(s) · Dushu Lake Hospital Affiliated to Soochow University · NCT06018363Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors
Phase 2 · 2 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT07424092Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
NA · 1 location(s) · Northwell Health · NCT05979064RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Phase 1 · 1 location(s) · University of Florida · NCT06389591LITT Followed by Hypofractionated RT for Recurrent Gliomas
NA · 4 location(s) · University of Maryland, Baltimore · NCT04181684
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.